CFO Invests $400K in Private Placement, Boosting Insider Confidence
APLM has more than doubled off its 52-week low of $3.659.
Summary
Apollomics' CFO, Peter Kuan-How Lin, purchased $400,005 worth of shares in a private placement, signaling strong insider confidence.
Key Events · Ownership and Investor Activity · APLM
-
CFO Investment
CFO Peter Kuan-How Lin acquired 26,667 shares for $400,005 at $15.00 per share as part of a private placement.
-
Insider Conviction
This purchase, representing a substantial portion of the company's market cap, follows recent significant investments by the CEO and a director-affiliated entity in the same private placement.
-
Context of Capital Raise
The private placement, which raised $10 million, provides crucial capital for the company, especially after recently resolving a Nasdaq delisting notice.
Analysis · APLM · Life Sciences
Apollomics' Chief Financial Officer, Peter Kuan-How Lin, has invested $400,005 in the company's recent private placement at $15.00 per share. This significant personal investment, following a $5.55 million investment by the CEO and a $300,000 investment by a director-affiliated entity, demonstrates strong insider conviction in the company's prospects, especially after the recent resolution of a Nasdaq delisting threat.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 40.7% of the 388 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, APLM was trading at $23.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $51.7M. The 52-week trading range was $3.66 to $42.12. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.